PURPOSE OF REVIEW: Despite current therapy, coronary artery disease (CAD) remains the major cause of morbidity and mortality worldwide. CAD is the consequence of a complex array of deranged metabolic processes including the immune system. In this context, monocytes and macrophages are indisputable players. Thus, monocyte gene expression analysis could be a powerful tool to provide new insights in the pathophysiology of CAD and improve identification of individuals at risk. We discuss current literature assessing monocyte gene expression and its association with CAD. RECENT FINDINGS: Monocyte surface markers CD14 ⁺⁺and CD16⁺ have been established as biomarkers for increased cardiovascular disease risk in a large number of studies. More in-depth gene expression analysis identified several interesting genes, such as ABCA1, CD36 and MSR1 with an increased expression in circulating monocytes from patients with CAD. The results for CD36 were replicated in one other study. For ABCA1 and MSR1 conflicting data are published. SUMMARY: Recent findings indicate that genetic differences exist in circulating monocytes of patients suffering from CAD, giving us more insights into the underlying mechanisms. However, larger studies are required to prove that monocytes' expression signature could serve as a marker for diagnostic purposes in the future.
PURPOSE OF REVIEW: Despite current therapy, coronary artery disease (CAD) remains the major cause of morbidity and mortality worldwide. CAD is the consequence of a complex array of deranged metabolic processes including the immune system. In this context, monocytes and macrophages are indisputable players. Thus, monocyte gene expression analysis could be a powerful tool to provide new insights in the pathophysiology of CAD and improve identification of individuals at risk. We discuss current literature assessing monocyte gene expression and its association with CAD. RECENT FINDINGS: Monocyte surface markers CD14 ⁺⁺and CD16⁺ have been established as biomarkers for increased cardiovascular disease risk in a large number of studies. More in-depth gene expression analysis identified several interesting genes, such as ABCA1, CD36 and MSR1 with an increased expression in circulating monocytes from patients with CAD. The results for CD36 were replicated in one other study. For ABCA1 and MSR1 conflicting data are published. SUMMARY: Recent findings indicate that genetic differences exist in circulating monocytes of patients suffering from CAD, giving us more insights into the underlying mechanisms. However, larger studies are required to prove that monocytes' expression signature could serve as a marker for diagnostic purposes in the future.
Authors: Ahmed Boghdady; Usama Ahmed Arafa; Eman A Sabet; Eman Salama; Ahmed El Sharawy; Mahmoud I Elbadry Journal: Cardiovasc Diagn Ther Date: 2016-04
Authors: Soraya M Kazuma; Marcela F Cavalcante; Andréia E R Telles; Andrea Queiroz Maranhão; Dulcineia S P Abdalla Journal: MAbs Date: 2013-07-25 Impact factor: 5.857
Authors: Ellis N Ter Horst; Paul A J Krijnen; Nazanin Hakimzadeh; Lourens F H J Robbers; Alexander Hirsch; Robin Nijveldt; Ingrid Lommerse; Ruud D Fontijn; Elisa Meinster; Ronak Delewi; Niels van Royen; Felix Zijlstra; Albert C van Rossum; C Ellen van der Schoot; Tineke C T M van der Pouw Kraan; Anton J Horrevoets; Anja M van der Laan; Hans W M Niessen; Jan J Piek Journal: Basic Res Cardiol Date: 2018-11-12 Impact factor: 17.165
Authors: Nicholas Felici; Da Liu; Josh Maret; Mariana Restrepo; Yuliya Borovskiy; Jihane Hajj; Wesley Chung; Krzysztof Laudanski Journal: Front Cardiovasc Med Date: 2021-11-15
Authors: Yongmei Liu; Lindsay M Reynolds; Jingzhong Ding; Li Hou; Kurt Lohman; Tracey Young; Wei Cui; Zhiqing Huang; Carole Grenier; Ma Wan; Hendrik G Stunnenberg; David Siscovick; Lifang Hou; Bruce M Psaty; Stephen S Rich; Jerome I Rotter; Joel D Kaufman; Gregory L Burke; Susan Murphy; David R Jacobs; Wendy Post; Ina Hoeschele; Douglas A Bell; David Herrington; John S Parks; Russell P Tracy; Charles E McCall; James H Stein Journal: Nat Commun Date: 2017-08-30 Impact factor: 17.694